MUKUNDA RAM 4

Accession 0001185185-24-000267

CIK 0001326205other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 3:52 PM ET

Size

32.9 KB

Accession

0001185185-24-000267

Form 4

Period: 2024-03-13

DirectorExec. Chairman & CEO

Transactions

Exercise/Conversion
Common Stock
2024-03-13+333,333→ 2,908,093 total
Exercise/Conversion
Common Stock
2024-03-13+251,250→ 3,726,011 total
Exercise/Conversion
Common Stock
2024-03-13+233,334→ 3,141,427 total
Exercise/Conversion
Common Stock
2024-03-13+333,334→ 3,474,761 total
Gift
Common Stock
2024-03-13−200,000→ 3,526,011 total
Exercise/Conversion
Restricted Stock Units
2024-03-13−333,333→ 0 total
→ Common Stock (333,333 underlying)
Award
Options
2024-03-13+1,000,002→ 0 total
Exp: 2034-03-12→ Common Stock (1,000,002 underlying)
Exercise/Conversion
Restricted Stock Units
2024-03-13−233,333→ 233,333 total
→ Common Stock (233,333 underlying)
Exercise/Conversion
Restricted Stock Units
2024-03-13−333,334→ 666,667 total
→ Common Stock (333,334 underlying)
Exercise/Conversion
Restricted Stock Units
2024-03-13−251,250→ 783,750 total
Exp: 2033-03-31→ Common Stock (251,250 underlying)
Award
Options
2024-03-13+1,500,000→ 0 total
Exp: 2034-03-12→ Common Stock (1,500,000 underlying)
Exercise/Conversion
Restricted Stock Units
2024-03-13−16,667→ 0 total(indirect: By Spouse)
→ Common Stock (16,667 underlying)
Exercise/Conversion
Restricted Stock Units
2024-03-13−16,667→ 33,333 total(indirect: By Spouse)
→ Common Stock (16,667 underlying)
Exercise/Conversion
Common Stock
2024-03-13+16,667→ 794,085 total(indirect: By Spouse)
Exercise/Conversion
Common Stock
2024-03-13+16,667→ 810,752 total(indirect: By Spouse)

Footnotes (8)

[F1]On July 19, 2021, the Reporting Person and the Reporting Person's spouse were granted RSUs subject to vesting equally over three and two years, respectively, and starting on March 31, 2022.
[F2]On May 25, 2022, the Reporting Person and the Reporting Person's spouse were granted RSUs subject to vesting equally over three years starting on March 31, 2023.
[F3]Gift of shares of the Company's common stock to the reporting person's children who do not share the reporting person's household.
[F4]On June 20, 2023, the Reporting Person and the Reporting Person's spouse were granted RSUs subject to vesting equally over three years starting on March 31, 2024.
[F5]On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. One milestone (156,750) was achieved, and one milestone (156,750) was not achieved.
[F6]Each restricted stock unit represents a right to receive one share of IGC common stock.
[F7]On March 13, 2024, the Reporting Person was granted options exercisable at $0.26, vesting over three years starting in March 2025.
[F8]On March 13, 2024, the Reporting Person was granted options exercisable at $0.26 vesting at the time that certain milestones set by the Board of Directors are achieved.

Documents

1 file

IGC Pharma, Inc.

CIK 0001326205

Entity typeother